Stage IV HER2-Positive Breast Cancer: Pilar's Patient Story
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Biomarkers
- Hormone receptor-positive; HER2-positive
- Sex
- Female
- Treatment
- chemotherapy, hormone therapy and targeted therapy
- Outcome
- Living With Cancer
Treatment course, step by step
- Metastatic hormone receptor-positive, HER2-positive breast cancer
- chemotherapy
- ongoing Zoladex, aromatase inhibitors, trastuzumab, and pertuzumab
- later pelvic-floor/genitourinary rehabilitation clinical study for treatment-related side effects, after oncologist review.
What happened, in summary
Pilar was 43 and living with metastatic hormone receptor-positive, HER2-positive breast cancer. Before cancer, she had trained as a special-education and early-childhood teacher, spent 14 years in Nicaragua, worked with young people and families affected by addiction, and built a family with her husband. After returning to Spain with her husband and 2 children, she was diagnosed with metastatic breast cancer. Pilar used many of the same tools she had once taught others: setting manageable goals, accepting help, writing down questions before oncology visits, and building support through family, friends, and social media. She explained the illness to her children, who were 6 and 9, by telling them honestly that because she was metastatic, she would need treatment for many years, while also making clear that she was not dying at that moment. Treatment included chemotherapy, followed by ongoing Zoladex, aromatase inhibitors, trastuzumab, and pertuzumab. Side effects included fatigue and genitourinary symptoms. After discussing the issue with her oncologist, Pilar entered a pelvic-floor rehabilitation study at Vall d’Hebron to help manage those effects. She continued sharing practical, emotionally honest updates online, focusing on family, daily joy, and adapting life around long-term treatment.
Where this story comes from
This is a lay summary of an account first published by MatchTrial Historias Reales. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer